Lazaridis KN - Search Results

1

Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities.

Goeppert B, Folseraas T, Roessler S, Kloor M, Volckmar AL, Endris V, Buchhalter I, Stenzinger A, Grzyb K, Grimsrud MM, Gornicka B, von Seth E, Reynolds GM, Franke A, Gotthardt DN, Mehrabi A, Cheung A, Verheij J, Arola J, Mäkisalo H, Eide TJ, Weidemann S, Cheville JC, Mazza G, Hirschfield GM, Ponsioen CY, Bergquist A, Milkiewicz P, Lazaridis KN, Schramm C, Manns MP, Färkkilä M, Vogel A; International PSC Study Group; Boberg KM, Schirmacher P, Karlsen TH. Goeppert B, et al. Among authors: lazaridis kn. Hepatology. 2020 Oct;72(4):1253-1266. doi: 10.1002/hep.31110. Epub 2020 Aug 19. Hepatology. 2020. PMID: 31925805

2

Liver mass in a patient with primary sclerosing cholangitis.

Lazaridis KN, Gores GJ. Lazaridis KN, et al. J Hepatol. 1999 Dec;31(6):1086. doi: 10.1016/s0168-8278(99)80332-8. J Hepatol. 1999. PMID: 10604584 No abstract available.

3

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

Lazaridis KN, Gores GJ, Lindor KD. Lazaridis KN, et al. J Hepatol. 2001 Jul;35(1):134-46. doi: 10.1016/s0168-8278(01)00092-7. J Hepatol. 2001. PMID: 11495032 Review.

4

Cholangiocarcinoma.

Lazaridis KN, Gores GJ. Lazaridis KN, et al. Gastroenterology. 2005 May;128(6):1655-67. doi: 10.1053/j.gastro.2005.03.040. Gastroenterology. 2005. PMID: 15887157 Review. No abstract available.

5

Primary sclerosing cholangitis and cholangiocarcinoma.

Lazaridis KN, Gores GJ. Lazaridis KN, et al. Semin Liver Dis. 2006 Feb;26(1):42-51. doi: 10.1055/s-2006-933562. Semin Liver Dis. 2006. PMID: 16496232 Review.

6

Genomics and complex liver disease: Challenges and opportunities.

Juran BD, Lazaridis KN. Juran BD, et al. Among authors: lazaridis kn. Hepatology. 2006 Dec;44(6):1380-90. doi: 10.1002/hep.21453. Hepatology. 2006. PMID: 17133459 Review.

7

Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis.

Lazaridis KN, Juran BD, Boe GM, Slusser JP, de Andrade M, Homburger HA, Ghosh K, Dickson ER, Lindor KD, Petersen GM. Lazaridis KN, et al. Hepatology. 2007 Sep;46(3):785-92. doi: 10.1002/hep.21749. Hepatology. 2007. PMID: 17680647

8

Sclerosing cholangitis epidemiology and etiology.

Lazaridis KN. Lazaridis KN. J Gastrointest Surg. 2008 Mar;12(3):417-9. doi: 10.1007/s11605-007-0344-3. Epub 2007 Oct 24. J Gastrointest Surg. 2008. PMID: 17957439 Review.

9

Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis.

Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Petersen GM, Lazaridis KN. Juran BD, et al. Among authors: lazaridis kn. Hepatology. 2008 Feb;47(2):563-70. doi: 10.1002/hep.22048. Hepatology. 2008. PMID: 18041714 Free PMC article.

10

Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.

Lazaridis KN. Lazaridis KN. Hepatology. 2008 Jan;47(1):8-10. doi: 10.1002/hep.22100. Hepatology. 2008. PMID: 18161699 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page